ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer

ERG Cooperates with Androgen Receptor in Regulating Trefoil Factor 3 in Prostate Cancer Disease Progression

(2015) David S. Rickman et al.   NEOPLASIA

Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer

(2015) Kyung Park et al.   NEOPLASIA

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naïve prostate cancer and are elevated in castration-resistant disease

(2013) Tobias Zellweger et al.   ENDOCRINE-RELATED CANCER

Autonomic Nerve Development Contributes to Prostate Cancer Progression

(2013) C. Magnon et al.   SCIENCE

ERG Protein Expression and Gene Rearrangements Are Present at Lower Rates in Metastatic and Locally Advanced Castration-resistant Prostate Cancer Compared to Localized Disease

(2013) Liang-Hong Teng et al.   UROLOGY

Clinical potential of the ERG oncoprotein in prostate cancer

(2012) Philip Rosen et al.   Nature Reviews Urology

ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies

(2012) M Braun et al.   PROSTATE CANCER AND PROSTATIC DISEASES

ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancer

(2012) Veit J. Scheble et al.   VIRCHOWS ARCHIV

ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma

(2011) Markku Miettinen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy

(2011) Sarah Minner et al.   CLINICAL CANCER RESEARCH

Common Gene Rearrangements in Prostate Cancer

(2011) Mark A. Rubin et al.   JOURNAL OF CLINICAL ONCOLOGY

Variability in the Androgen Response of Prostate Epithelium to 5 -Reductase Inhibition: Implications for Prostate Cancer Chemoprevention

(2010) E. A. Mostaghel et al.   CANCER RESEARCH

Testing mutual exclusivity of ETS rearranged prostate cancer

(2010) Maria A Svensson et al.   LABORATORY INVESTIGATION

TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features

(2010) Samson W Fine et al.   MODERN PATHOLOGY

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

(2010) B Furusato et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer

(2009) C. Cai et al.   CANCER RESEARCH

Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States

(2009) J.-M. Mosquera et al.   CLINICAL CANCER RESEARCH

ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice

(2009) Scott A. Tomlins et al.   EUROPEAN UROLOGY

ETS gene fusions in prostate cancer

(2009) Jeremy P. Clark et al.   Nature Reviews Urology

Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer

(2008) R. Mehra et al.   CANCER RESEARCH